Press Release|Articles|April 14, 2025
Camber Pharmaceuticals Launches Lurasidone Hydrochloride Tablets
Listen
0:00 / 0:00
Key Takeaways
- Lurasidone Hydrochloride Tablets treat schizophrenia in adults and adolescents aged 13 to 17 years.
- They address depressive episodes in Bipolar I Disorder for adults and pediatric patients aged 10 to 17.
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Lurasidone Hydrochloride Tablets.
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of:
- Schizophrenia in adults and adolescents (13 to 17 years)
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy
- Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate
Lurasidone Hydrochloride Tablets in 20 mg, 40 mg, 60 mg, 80 mg, 120 mg strengths are available in 30-count bottles.
To find out more information on Lurasidone Hydrochloride Tablets, please visit:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
Expert Discusses Early Safety and Tolerability Findings for VMT-α-NET in Neuroendocrine Tumors | ESMO 2025
5
